tara seery, md: clinical data supporting regorafenib in mcrc
Published 8 years ago • 136 plays • Length 0:51Download video MP4
Download video MP3
Similar videos
-
0:46
tara seery, md: clinical data supporting trifluradine-tipiracil
-
0:36
tara seery, md: mechanisms of action in regorafenib
-
1:00
tara seery, md: regorafenib dose adjustments
-
0:58
tara seery, md: reinitiating regorafenib in patients with mcrc
-
1:01
tara seery, md: fourth-line therapy in mcrc
-
1:20
tanios bekaii-saab, md: clinical data supporting regorafenib in mcrc
-
0:31
tara seery, md; chemotherapy as a possible option
-
0:22
tara seery, md: kras status in mcrc
-
1:07
tara seery, md: impact of third-line therapy
-
0:28
tanios bekaii-saab, md: reinitiating regorafenib in patients with mcrc
-
0:51
philip philip, md explains how to integrate regorafenib and trifluridine for 2nd line mcrc treatment
-
5:32
colorectal cancer: regorafenib patient selection and dosing
-
1:12
tanios bekaii-saab, md: mechanisms of action in regorafenib
-
1:21
tanios bekaii-saab, md: regorafenib dose adjustments
-
0:58
dr. kim reviews studies investigating regorafenib in mcrc
-
9:34
regorafenib in colorectal cancer
-
1:40
tanios bekaii-saab, md: clinical data supporting trifluradine-tipiracil
-
8:26
regorafenib in advanced colorectal cancer: dosing strategies
-
1:12
efficacy of tas-102 continues to hold up in metastatic crc and gastric cancers